title: Pharmacogenetic dose refinement prevents warfarin overdose in a patient who is highly warfarin-sensitive.
authors.forename: G R
authors.initials: GR
authors.lastname: Grice
authors.forename: P E
authors.initials: PE
authors.lastname: Milligan
authors.forename: C
authors.initials: C
authors.lastname: Eby
authors.forename: B F
authors.initials: BF
authors.lastname: Gage
mesh_terms: D000368:Aged; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics; D062787:Drug Overdose / Q000517:prevention & control*; D005838:Genotype; D006801:Humans; D019934:International Normalized Ratio; D008297:Male; D006899:Mixed Function Oxygenases / Q000235:genetics; D010597:Pharmacogenetics / Q000379:methods*; D013250:Steroid Hydroxylases / Q000235:genetics; D064417:Vitamin K Epoxide Reductases; D014859:Warfarin / Q000008:administration & dosage*
chemical_list: D014859:Warfarin; D006899:Mixed Function Oxygenases; D013250:Steroid Hydroxylases; D001189:Aryl Hydrocarbon Hydroxylases; C029009:steroid hormone 7-alpha-hydroxylase; D064417:Vitamin K Epoxide Reductases